Trial site
Suncoast Clinical Research, Inc.
- 17running trials
- 20closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Obesity14 trials
- Type 2 diabetes11 trials
- Alzheimer disease10 trials
- Type 1 diabetes3 trials
- Chronic kidney disease2 trials
- Osteoarthritis2 trials
- Rheumatoid arthritis2 trials
- Coronary artery disease1 trial
- Cushing's syndrome1 trial
- Frontotemporal dementia1 trial
- Heart failure1 trial
- High blood pressure1 trial
- and 3 more
- Phase
- Phase 322 trials
- Phase 215 trials
- Phase 41 trial
- Status
- Completed17 trials
- Recruiting8 trials
- Active, not recruiting6 trials
- Not yet recruiting3 trials
- Terminated3 trials
- Suspended1 trial
- Lead sponsor
- Eli Lilly and Company23 trials
- Novo Nordisk A/S5 trials
- Cassava Sciences, Inc.2 trials
- Alfasigma S.p.A.1 trial
- Amgen1 trial
- and 6 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
Recruiting
Recruiting
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity5 recruiting
- Type 2 diabetes4 recruiting
- Osteoarthritis2 recruiting
- Alzheimer disease1 recruiting
- Cushing's syndrome1 recruiting
- Heart failure1 recruiting
- Sjögren's disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Recruiting
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Completed
Completed
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026